SK108293A3 - Anti-tumor and anti-psoriatic agents - Google Patents
Anti-tumor and anti-psoriatic agents Download PDFInfo
- Publication number
- SK108293A3 SK108293A3 SK1082-93A SK108293A SK108293A3 SK 108293 A3 SK108293 A3 SK 108293A3 SK 108293 A SK108293 A SK 108293A SK 108293 A3 SK108293 A3 SK 108293A3
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- alkyl
- formula
- water
- mixture
- Prior art date
Links
- 0 **(CC1)C=Cc2c1[n]c1c2c(*)c(*)c2c1[n]c1c2C=C*C=C1 Chemical compound **(CC1)C=Cc2c1[n]c1c2c(*)c(*)c2c1[n]c1c2C=C*C=C1 0.000 description 5
- KZFMHGCPJHDUPE-UXHICEINSA-N Cc1ccc2[n]([C@H]3O[C@@H]4CC3)c3c5[n]4c(ccc([Cl]=C)c4)c4c5c(CNC4=O)c4c3c2c1 Chemical compound Cc1ccc2[n]([C@H]3O[C@@H]4CC3)c3c5[n]4c(ccc([Cl]=C)c4)c4c5c(CNC4=O)c4c3c2c1 KZFMHGCPJHDUPE-UXHICEINSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68377091A | 1991-04-11 | 1991-04-11 | |
| PCT/US1992/002661 WO1992018507A1 (fr) | 1991-04-11 | 1992-04-09 | Agents antitumoraux et antipsoriasiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK108293A3 true SK108293A3 (en) | 1994-09-07 |
Family
ID=24745378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1082-93A SK108293A3 (en) | 1991-04-11 | 1992-04-09 | Anti-tumor and anti-psoriatic agents |
Country Status (14)
| Country | Link |
|---|---|
| EP (2) | EP0580812A1 (fr) |
| JP (1) | JPH06503837A (fr) |
| CA (1) | CA2108146A1 (fr) |
| CZ (1) | CZ213693A3 (fr) |
| FI (1) | FI934461A0 (fr) |
| HU (1) | HUT70187A (fr) |
| IE (1) | IE921148A1 (fr) |
| IL (1) | IL101554A0 (fr) |
| MX (1) | MX9201643A (fr) |
| NO (1) | NO933611L (fr) |
| NZ (1) | NZ242294A (fr) |
| SK (1) | SK108293A3 (fr) |
| TW (1) | TW214553B (fr) |
| WO (1) | WO1992018507A1 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0575955B1 (fr) * | 1992-06-22 | 1999-09-15 | Kyowa Hakko Kogyo Co., Ltd. | Procédé pour la préparation de dérivés de staurosporine |
| AU5100393A (en) * | 1992-09-25 | 1994-04-26 | Schering Corporation | Diindolo compounds and pharmaceutical compositions containing them |
| US5624949A (en) * | 1993-12-07 | 1997-04-29 | Eli Lilly And Company | Protein kinase C inhibitors |
| US5843935A (en) * | 1993-12-07 | 1998-12-01 | Eli Lilly And Company | Protein kinase C inhibitors |
| CA2137203C (fr) * | 1993-12-07 | 2006-11-28 | William Francis Heath Jr. | Inhibiteurs de la proteine kinase c |
| US5723456A (en) * | 1993-12-07 | 1998-03-03 | Eli Lilly & Company | Therapeutic treatment for cardiovascular diseases |
| WO1995022331A1 (fr) * | 1994-02-18 | 1995-08-24 | Cephalon, Inc. | Solutions aqueuses d'indolocarbazole |
| AU6657596A (en) * | 1995-07-31 | 1997-02-26 | Ciba-Geigy Ag | Trindene compounds |
| US20040037828A1 (en) | 2002-07-09 | 2004-02-26 | Bar-Ilan University | Methods and pharmaceutical compositions for healing wounds |
| FR2826653B1 (fr) * | 2001-06-29 | 2005-10-14 | Servier Lab | Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TW201041580A (en) | 2001-09-27 | 2010-12-01 | Alcon Inc | Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| ZA200601089B (en) | 2003-08-07 | 2007-05-30 | Hearlor Ltd | Pharmaceutical compositions and methods for accelerating wound healing |
| ZA200802546B (en) | 2005-08-29 | 2009-10-28 | Healor Ltd | Methods and compositions for prvention and treatment of diabetic and aged skin |
| EP2181999A1 (fr) | 2008-11-03 | 2010-05-05 | Zentiva, A.S. | Procédé de fabrication d'un ruboxistaurine |
| JP2013516500A (ja) | 2010-01-11 | 2013-05-13 | ヒールオア・リミテッド | 炎症性疾患および障害を治療するための方法 |
| JP2017524739A (ja) | 2014-07-17 | 2017-08-31 | アンセルムＩｎｓｅｒｍ | 神経筋接合部関連疾患の処置方法 |
| WO2016207366A1 (fr) | 2015-06-26 | 2016-12-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Méthodes et compositions pharmaceutiques de traitement d'infections virales |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923986A (en) * | 1987-03-09 | 1990-05-08 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of physiologically active substance K-252 |
| DE3924538A1 (de) * | 1989-07-25 | 1991-01-31 | Goedecke Ag | Indolocarbazol und dessen verwendung |
-
1992
- 1992-04-09 IL IL101554A patent/IL101554A0/xx unknown
- 1992-04-09 CA CA002108146A patent/CA2108146A1/fr not_active Abandoned
- 1992-04-09 TW TW081102729A patent/TW214553B/zh active
- 1992-04-09 NZ NZ242294A patent/NZ242294A/en unknown
- 1992-04-09 EP EP92917468A patent/EP0580812A1/fr active Pending
- 1992-04-09 CZ CS932136A patent/CZ213693A3/cs unknown
- 1992-04-09 SK SK1082-93A patent/SK108293A3/sk unknown
- 1992-04-09 EP EP92303187A patent/EP0508792A1/fr not_active Withdrawn
- 1992-04-09 WO PCT/US1992/002661 patent/WO1992018507A1/fr not_active Application Discontinuation
- 1992-04-09 JP JP4510240A patent/JPH06503837A/ja active Pending
- 1992-04-09 MX MX9201643A patent/MX9201643A/es unknown
- 1992-04-09 HU HU9302869A patent/HUT70187A/hu unknown
- 1992-04-10 IE IE114892A patent/IE921148A1/en unknown
-
1993
- 1993-10-08 NO NO93933611A patent/NO933611L/no unknown
- 1993-10-11 FI FI934461A patent/FI934461A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI934461A (fi) | 1993-10-11 |
| TW214553B (fr) | 1993-10-11 |
| EP0508792A1 (fr) | 1992-10-14 |
| AU646163B2 (en) | 1994-02-10 |
| AU1798292A (en) | 1992-11-17 |
| NO933611D0 (no) | 1993-10-08 |
| CZ213693A3 (en) | 1994-05-18 |
| IE921148A1 (en) | 1992-10-21 |
| WO1992018507A1 (fr) | 1992-10-29 |
| NO933611L (no) | 1993-10-08 |
| CA2108146A1 (fr) | 1992-10-12 |
| JPH06503837A (ja) | 1994-04-28 |
| EP0580812A1 (fr) | 1994-02-02 |
| IL101554A0 (en) | 1992-12-30 |
| HUT70187A (en) | 1995-09-28 |
| MX9201643A (es) | 1992-10-01 |
| FI934461A0 (fi) | 1993-10-11 |
| NZ242294A (en) | 1993-07-27 |
| HU9302869D0 (en) | 1993-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK108293A3 (en) | Anti-tumor and anti-psoriatic agents | |
| DE68910421T2 (de) | DC-88A-Derivate. | |
| US4981968A (en) | Synthesis of camptothecin and analogs thereof | |
| AU757510C (en) | Pyrrolobenzodiazepines | |
| KR100312445B1 (ko) | 트리플루오로메틸피롤로인돌카르복실산 에스테르 유도체의 제조방법 | |
| US5122526A (en) | Camptothecin and analogs thereof and pharmaceutical compositions and method using them | |
| EP3919488A1 (fr) | Immunomodulateur | |
| KR100189043B1 (ko) | 갈란타민 유도체 및 이를 함유하는 약제학적 조성물 | |
| RU2129546C1 (ru) | 6,9-бис(аминозамещенные)-бензо(g)изохинолин-5,10-дионы, способ их получения, фармацевтическая композиция на их основе и способ ингибирования опухолей у млекопитающих | |
| JPH08506356A (ja) | 抗癌遺伝子剤および抗癌剤としてのアンサマイシン誘導体 | |
| CA2082820C (fr) | Derives 6-aminooctahydroindolizinetriol | |
| PL175707B1 (pl) | Nowe estry 1-aryloksy-3-alkiloamino-2-propanolu | |
| RU2200737C2 (ru) | Пиримидо[4,5-b]индолы и промежуточное соединение (варианты) | |
| US5519029A (en) | 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones | |
| JPH08509740A (ja) | カンプトテシンの水溶性誘導体 | |
| EP0662076B1 (fr) | Isoquinoindazole-6-(2h)-ones a substitution 2-aminoalkyle-5-aminoalkylamino, a activite antitumorale | |
| HU203886B (en) | Process for producing 12-halogeno-forscholine derivatives and pharmaceutical compositions contining them as active components | |
| AU646163C (en) | Anti-tumor and anti-psoriatic agents | |
| KR100390767B1 (ko) | 아지리디닐퀴놀린디온 유도체와 그의 제조방법 | |
| AU767089B2 (en) | Process to prepare (5R)-(methylamino)-5,6-dihydro-4H- imidazo(4,5,1-ij)-quinolin-2(1H)-one | |
| US5604246A (en) | 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones | |
| RU2154066C2 (ru) | Бензотиопираноиндазолы, фармацевтическая композиция на их основе и способ лечения опухоли | |
| WO1995024407A1 (fr) | Indazoles hetero-anneles | |
| JP2003506376A (ja) | １，２−ジヒドロ−１−オキソ−ピラジノ［１，２−ａ］インドール誘導体 | |
| CZ286654B6 (cs) | 2-/2-/(2-hydroxyethyl) amino/ethyl/-5-//(2-methylamino)ethyl/amino/indazol/4,3-gh/isochinolin-6(2H) on, způsob jeho výroby a farmaceutický prostředek s jeho obsahem |